Updates and current challenges in microRNA research for personalized medicine in ovarian cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Updates and current challenges in microRNA research for personalized medicine in ovarian cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 17, Issue 8, Pages 927-943
Publisher
Informa UK Limited
Online
2017-06-23
DOI
10.1080/14712598.2017.1340935
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-376a promotion of proliferation and metastases in ovarian cancer: Potential role as a biomarker
- (2017) Liu Yang et al. LIFE SCIENCES
- MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression
- (2017) Wen-Ting Chen et al. Journal of Ovarian Research
- Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene
- (2016) Junbao Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
- (2016) Pinar Kanlikilicer et al. CANCER RESEARCH
- MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein
- (2016) Xiaoyan Ying et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity
- (2016) Aymone Gurtner et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regulatory mechanisms of microRNA expression
- (2016) Lyudmila F. Gulyaeva et al. Journal of Translational Medicine
- Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
- (2016) Marina Bagnoli et al. LANCET ONCOLOGY
- Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
- (2016) Jonathan A Ledermann et al. LANCET ONCOLOGY
- Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer
- (2016) Zhentong Wei et al. MEDICAL ONCOLOGY
- Clinical relevance of circulating cell-free microRNAs in ovarian cancer
- (2016) Koji Nakamura et al. Molecular Cancer
- Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy
- (2016) Nicolas Vigneron et al. Molecular Oncology
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward the promise of microRNAs – Enhancing reproducibility and rigor in microRNA research
- (2016) Kenneth W. Witwer et al. RNA Biology
- Extracellular miRNA: A Collision of Two Paradigms
- (2016) Andrey Turchinovich et al. TRENDS IN BIOCHEMICAL SCIENCES
- MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1
- (2016) Di-di Wu et al. TUMOR BIOLOGY
- Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer
- (2016) Glen Reid et al. Epigenomics
- A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
- (2016) Sherry Y. Wu et al. Nature Communications
- Inhibition of miR-21 in glioma cells using catalytic nucleic acids
- (2016) Agnieszka Belter et al. Scientific Reports
- Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1 -Mutant Ovarian Cancer
- (2016) Young Eun Choi et al. Cell Reports
- Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer
- (2016) Pradeep Chaluvally-Raghavan et al. Cell Reports
- CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo
- (2016) Hong Chang et al. Scientific Reports
- Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
- (2015) Huiyuan Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma
- (2015) M. H. van der Ree et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer
- (2015) Anil Belur Nagaraj et al. Biomarkers in Medicine
- Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
- (2015) Xiaodan Meng et al. BRITISH JOURNAL OF CANCER
- A novel serum microRNA panel to discriminate benign from malignant ovarian disease
- (2015) Ream Langhe et al. CANCER LETTERS
- MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression
- (2015) Shuo Chen et al. CANCER LETTERS
- Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
- (2015) M. Zuberi et al. Clinical & Translational Oncology
- Data Normalization Strategies for MicroRNA Quantification
- (2015) H. Schwarzenbach et al. CLINICAL CHEMISTRY
- MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer
- (2015) Xiaobo Chen et al. GYNECOLOGIC ONCOLOGY
- Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review
- (2015) Maria Guadalupe Patrono et al. GYNECOLOGIC ONCOLOGY
- MicroRNAs in Ovarian Cancer
- (2015) Betina Katz et al. HUMAN PATHOLOGY
- Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration
- (2015) Thomas A. Olson et al. JOURNAL OF CLINICAL ONCOLOGY
- Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
- (2015) Guoyan Liu et al. JNCI-Journal of the National Cancer Institute
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression
- (2015) Xi Chen et al. Molecular Cancer
- Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis
- (2015) A K Mitra et al. ONCOGENE
- miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
- (2015) X Zhu et al. ONCOGENE
- Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer
- (2015) E G Seviour et al. ONCOGENE
- Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study
- (2015) Luděk Záveský et al. PATHOLOGY & ONCOLOGY RESEARCH
- Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study
- (2015) Eric A. Benson et al. PLoS One
- Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway
- (2015) Shuo Chen et al. PLoS One
- MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer
- (2015) Ying-chun Gao et al. TUMOR BIOLOGY
- Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression
- (2015) Xin Zhang et al. Oncotarget
- MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4
- (2015) Jiaxin Lin et al. Oncotarget
- MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
- (2015) Shaohua Xu et al. Oncotarget
- Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
- (2015) Guoyan Liu et al. JNCI-Journal of the National Cancer Institute
- Tissue miR-193b as a Novel Biomarker for Patients with Ovarian Cancer
- (2015) Haiyan Li et al. MEDICAL SCIENCE MONITOR
- miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
- (2015) Ruifen Dong et al. Oncotarget
- MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer
- (2015) Yue Zhang et al. Oncotarget
- Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients
- (2014) Meike H. van der Ree et al. ANTIVIRAL RESEARCH
- MicroRNAs: Biogenesis, Roles for Carcinogenesis and as Potential Biomarkers for Cancer Diagnosis and Prognosis
- (2014) Nowroji Kavitha et al. Asian Pacific Journal of Cancer Prevention
- Exosome-derived miRNAs and ovarian carcinoma progression
- (2014) Olga Vaksman et al. CARCINOGENESIS
- Good guy or bad guy: the opposing roles of microRNA 125b in cancer
- (2014) Julia Banzhaf-Strathmann et al. Cell Communication and Signaling
- MicroRNA-302b Suppresses Human Epithelial Ovarian Cancer Cell Growth by Targeting RUNX1
- (2014) Tingting Ge et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- New Strategies in Ovarian Cancer: Translating the Molecular Complexity of Ovarian Cancer into Treatment Advances
- (2014) J. Liu et al. CLINICAL CANCER RESEARCH
- microRNAs as Anti-Cancer Therapy
- (2014) Michela Garofalo et al. CURRENT PHARMACEUTICAL DESIGN
- MiR-718 represses VEGF and inhibits ovarian cancer cell progression
- (2014) Ruobing Leng et al. FEBS LETTERS
- miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
- (2014) Xiaolan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating microRNA expression profiles in ovarian cancer
- (2014) L. Ayaz et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer
- (2014) Lin Wang et al. PLoS One
- HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer
- (2014) Blanca Ortiz-Muñoz et al. TUMOR BIOLOGY
- miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation
- (2014) C Denoyelle et al. Cell Death & Disease
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
- (2014) Aditya Parikh et al. Nature Communications
- Identification of Serum MicroRNA-21 as a Biomarker for Early Detection and Prognosis in Human Epithelial Ovarian Cancer
- (2013) Yun-Zhao Xu et al. Asian Pacific Journal of Cancer Prevention
- Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation
- (2013) Ying Chen et al. Cancer Cell International
- Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer
- (2013) S. Suryawanshi et al. CLINICAL CANCER RESEARCH
- Ovarian cancer screening—Current status, future directions
- (2013) Usha Menon et al. GYNECOLOGIC ONCOLOGY
- Detection of MicroRNA as Novel Biomarkers of Epithelial Ovarian Cancer From the Serum of Ovarian Cancer Patient
- (2013) Ye-Won Chung et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells
- (2013) Mi Kwon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-106a Represses the Rb Tumor Suppressor p130 to Regulate Cellular Proliferation and Differentiation in High-Grade Serous Ovarian Carcinoma
- (2013) Z. Liu et al. MOLECULAR CANCER RESEARCH
- Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
- (2013) Hong Zheng et al. PLoS One
- A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
- (2013) A. Vecchione et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor
- (2013) Jinling Guo et al. TUMOR BIOLOGY
- MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
- (2013) Dengyu Chen et al. Journal of Ovarian Research
- Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
- (2012) Casina WS Kan et al. BMC CANCER
- MicroRNA Expression Signatures in Solid Malignancies
- (2012) Marco Galasso et al. CANCER JOURNAL
- Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
- (2011) C. C. Pritchard et al. Cancer Prevention Research
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
- (2010) D. C. Corney et al. CLINICAL CANCER RESEARCH
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
- (2009) E K O Ng et al. GUT
- A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
- (2009) Xiaoxia Hu et al. GYNECOLOGIC ONCOLOGY
- Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer
- (2009) Parag P Shah et al. Journal of Ovarian Research
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
- (2008) Kimberly E. Resnick et al. GYNECOLOGIC ONCOLOGY
- MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
- (2008) Neetu Dahiya et al. PLoS One
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now